cerrar
Tagged with Global

Top 20 Companies for Access to Medicine 2021
The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and development, and product delivery indices.…

Jean-Paul Clozel – CEO, Idorsia
In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

Top 10 Global Generics & Biosimilars Companies
The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for 2019. Sandoz leads the way in…

Population Health: Access & AntiVax Challenges
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…

Viatris: Cost-Cutting Needed at New Generics Behemoth
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Stefan Hendriks – Global Head Cell & Gene, Novartis…
Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in…

JP Morgan 2021 Virtual Healthcare Conference: A Course Correction…
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in…

Embryonic Gene Editing: How Far is Too Far to Find a Treatment…
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…

Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…

Top 4 Global Vaccine Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…

Securing Trust in the COVID-19 Supply Chain: From Development…
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19 vaccine.[1] As rollouts become…

Larry St Onge – President, Life Sciences and Healthcare,…
DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented cross-industry collaboration that…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here